Trimedyne, Inc. (TMED) Balance Sheet

Cash and cash equivalents
Trade accounts receivable, net of allowance for doubtful accounts of $12,000 at June 30, 2011 and September 30, 2010
Inventories
Other current assets
Total current assets
Property and equipment, net
Other
Goodwill
Total Assets
Accounts payable
Accrued expenses
Deferred revenue
Accrued warranty
Income tax payable
Current portion of note payable and capital leases
Current portion of note payable to related party
Accrued interest due to related party
Total current liabilities
Note payable and capital leases, net of current portion
Senior secured convertible note to related party, net of discount of $99,000 at September 30, 2010
Deferred rent
Derivative liabilities
Total liabilities
Commitments and contingencies
Preferred stock - $0.01 par value, 1,000,000 shares authorized, none issued and outstanding
Common stock - $0.01 par value, 30,000,000 shares authorized, 18,497,569 shares issued at June 30, 2011 and September 30, 2010, 18,395,960 shares outstanding at June 30, 2011 and September 30, 2010
Additional paid-in capital
Accumulated deficit
[StockholdersEquityBeforeTreasuryStock]
Treasury stock, at cost (101,609 shares)
Total stockholders' equity
Total liabilities and stockholder's equity

Entities mentioned with TMED

View All Entities